BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25956487)

  • 1. Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.
    Zhao LN; Yu T; Lan SY; Hou JT; Zhang ZZ; Wang SS; Liu FB
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):674-82. PubMed ID: 25956487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy.
    Shukla S; Shukla A; Mehboob S; Guha S
    Aliment Pharmacol Ther; 2011 Mar; 33(6):662-71. PubMed ID: 21251030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
    Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
    Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.
    Bai M; Yang Z; Qi X; Fan D; Han G
    J Gastroenterol Hepatol; 2013 May; 28(5):783-92. PubMed ID: 23425108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
    Cai XJ; Wang L; Hu CM
    J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
    Viramontes Hörner D; Avery A; Stow R
    J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of microbiome therapies for hepatic encephalopathy.
    Gao J; Nie R; Chang H; Yang W; Ren Q
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):927-937. PubMed ID: 37505972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in management of hepatic encephalopathy.
    Sharma BC; Singh J
    Metab Brain Dis; 2016 Dec; 31(6):1295-1301. PubMed ID: 27121846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials.
    Xu J; Ma R; Chen LF; Zhao LJ; Chen K; Zhang RB
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):354-60. PubMed ID: 25100119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy.
    Holte K; Krag A; Gluud LL
    Hepatol Res; 2012 Oct; 42(10):1008-15. PubMed ID: 22548675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Butterworth RF; Kircheis G; Hilger N; McPhail MJW
    J Clin Exp Hepatol; 2018 Sep; 8(3):301-313. PubMed ID: 30302048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
    Saji S; Kumar S; Thomas V
    Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence.
    Zhong C; Qu C; Wang B; Liang S; Zeng B
    J Clin Gastroenterol; 2017 Apr; 51(4):300-311. PubMed ID: 28267052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy.
    Ding X; Zhang F; Wang Y
    Aliment Pharmacol Ther; 2014 May; 39(9):1000. PubMed ID: 24689351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.